You are here: Welcome » pharmaceutical_companies » DynPort Vaccine Company

Differences

This shows you the differences between two versions of the page.

Link to this comparison view

Both sides previous revisionPrevious revision
Next revision		Previous revision
Both sides next revision
pharmaceutical_companies:dynport_vaccine_company [2023/03/20 21:08]
liam 		pharmaceutical_companies:dynport_vaccine_company [2024/10/30 17:59] (current)
liam [External links]
Line 7: Line 7:
 ===== History ===== ===== History =====
  
-DynPort was founded in 1997 as a joint venture between defense contractor [[:DynCorp]] and [[:Porton International]], a wholly-owned subsidiary of [[Ipsen]].((Hogan, B. (January/February 2002). //A Biodefense Boondoggle.// Mother Jones. https://web.archive.org/web/20051129154849/http://www.motherjones.com//news/outfront/2002/01/biodefense.html)) ((Harris, R. B. (2004, March 30). //Commonwealth Biotechnologies, Inc. Launches New Biodefense Business Initiative.// Securities and Exchange Commission. http://archive.today/2023.03.20-195208/https://www.sec.gov/Archives/edgar/data/1042418/000119312504053263/dex991.htm))+DynPort was founded in 1997 as a joint venture between defense contractor [[:DynCorp]] and [[:Porton International]], a wholly-owned subsidiary of [[Ipsen]].((Hogan, B. (January/February 2002). //A Biodefense Boondoggle.// Mother Jones. https://web.archive.org/web/20051129154849/http://www.motherjones.com//news/outfront/2002/01/biodefense.html)) ((Harris, R. B. (2004, March 30). //Commonwealth Biotechnologies, Inc. Launches New Biodefense Business Initiative.// Securities and Exchange Commission. http://archive.today/2023.03.20-195208/https://www.sec.gov/Archives/edgar/data/1042418/000119312504053263/dex991.htm)) That year, the [[:United States Department of Defense]] (DoD), through its [[:Joint Vaccine Acquisition Program]] (JVAP), contracted DynPort to manufacture 300,000 doses of a new [[:smallpox vaccine]] for the military.((Cohen, J., & Marshall, E. (2001, October 19). //Vaccines for Defense: A System in Distress.// UCLA Department of Epidemiology. http://archive.today/2021.12.13-221406/http://www.ph.ucla.edu/epi/bioter/vaccinesfordefense.html)) The company began working on the project in 1998. 
 + 
 +Dr. [[:Robert Malone]] joined the company as Associate Director of Clinical Research in 2002, leaving the position in 2003.((Malone, R. W. (2017, March). //RWM CV.// Squarespace. https://web.archive.org/web/20230119104151/https://static1.squarespace.com/static/550b0ac4e4b0c16cdea1b084/t/58e5406b5016e1f1acacae75/1491419246742/RWM+CV+March+2017.pdf)) 
 + 
 +Puppet Masters of the Pandemic. Part 1: What Did The CIA Do in Wuhan?" 
 +Part 1 of an interview with the New American Magazine - [[Robert Malone]] Aug 3, 2023 
 + 
 +We know that with the biodefense enterprise, broadly writ, in the United States, the CIA is intimately integrated into all levels. That's why I have all these [[CIA]] contacts is that I was brought into the biodefense community after 9/11 when I went to work for DynPort Vaccine company (because the Norwegian investors in the newco which Jill and I helped launch had pulled out after 9-11 and we had no income). ((https://web.archive.org/web/20230803144307/https://rwmalonemd.substack.com/p/puppet-masters-of-the-pandemic-part))
  
 On March 30, 2004, [[Commonwealth Biotechnologies]] announced it had entered a partnership with DynPort through which the companies would "co-venture wherever appropriate to compete for new biodefense vaccine development funding."((Harris, R. B. (2004, March 30). //Commonwealth Biotechnologies, Inc. Launches New Biodefense Business Initiative.// Securities and Exchange Commission. http://archive.today/2023.03.20-195208/https://www.sec.gov/Archives/edgar/data/1042418/000119312504053263/dex991.htm)) On March 30, 2004, [[Commonwealth Biotechnologies]] announced it had entered a partnership with DynPort through which the companies would "co-venture wherever appropriate to compete for new biodefense vaccine development funding."((Harris, R. B. (2004, March 30). //Commonwealth Biotechnologies, Inc. Launches New Biodefense Business Initiative.// Securities and Exchange Commission. http://archive.today/2023.03.20-195208/https://www.sec.gov/Archives/edgar/data/1042418/000119312504053263/dex991.htm))
  
 ===== Activities ===== ===== Activities =====
 +
 +==== Covid-19 Pandemic Cures ====
 +
 +A Killer Enterprise: How One of Big Pharma’s Most Corrupt Companies Plans to Corner the Covid-19 Cure Market 
 +
 +BY WHITNEY WEBB APRIL 9, 2020 Originally published at The Last American Vagabond 
 +
 +“One of the most politically-connected yet scandal ridden vaccine companies in the United States, with troubling ties to the 2001 [[anthrax]] attacks and opioid crisis, is set to profit handsomely from the current Coronavirus crisis.“ 
 +
 +
 +In August 2001, biopharmaceutical company [[BioPort]] faced imminent disaster. A series of company scandals, controversial federal bail-outs and severe, adverse health reactions among U.S. troops were causing both Congress and the Pentagon to reconsider its multi-million dollar contract to provide the military with an [[anthrax vaccine]]. 
 +
 +
 +Formed for the sole purpose of acquiring a publicly-owned company in Michigan that held the exclusive license to manufacture the only FDA-approved anthrax vaccine in the United States, BioPort sought to quickly expand the size and scope of its contracts with the U.S. military. This strategy was made possible thanks to the former head of the Joints Chiefs of Staff, Adm. [[William Crowe]], who would prove highly instrumental in the rise of BioPort’s vaccine monopoly and its subsequent, aggressive hiring of former 
 +government officials as lobbyists. 
 +
 +
 +Yet, soon after scoring these multi-million dollar contracts and securing a monopoly on anthrax vaccines, BioPort would claim that they were flailing financially and would subsequently be bailed out to the tune of $24 million at the Pentagon’s request, which cited “national security concerns” as justification. 
 +
 +BioPort would be then renamed and repackaged as [[Emergent Biosolutions]] in 2004. ((https://archive.org/stream/0000-00-00-00-whitney-webb-00/2020-04-09_A%20Killer%20Enterprise_%20How%20One%20of%20Big%20Pharma%27s%20Most%20Corrupt%20Companies%20Plans%20to%20Corner%20the%20Covid-19%20Cure%20Market_djvu.txt))
  
 ==== Products ==== ==== Products ====
Line 30: Line 57:
  
 ^ Name  ^ Position  ^ Notes  ^ ^ Name  ^ Position  ^ Notes  ^
-| [[:Terry Irgens]]  | President (former)  | -  |+| [[:Terry Irgens]]  | President (former)  | [[:Logicon]], [[:Defense Personnel Support Center]], [[:Naval Medical Logistics Command]] (NMLC)  | 
 +| [[:Michael Langford]]  | Sr. Vice President & Chief Scientific Officer (former)((//Leadership.// DynPort. Retrieved December 8, 2002, from https://web.archive.org/web/20021208085639/http://www.dynport.com/leadership.htm))  | [[:United States Army]], [[:United States Army Acquisition Corps]]  | 
 +| [[:Robert Malone]]  | Associate Director of Clinical Research (former)  | Worked on DynPort's smallpox vaccine  |
  
 ===== External links ===== ===== External links =====
Line 37: Line 66:
   * [[https://sourcewatch.org/index.php/DynPort|SourceWatch]]   * [[https://sourcewatch.org/index.php/DynPort|SourceWatch]]
   * [[https://web.archive.org/web/20021123050047/http://www.dynport.com/|Website (earliest archive)]]   * [[https://web.archive.org/web/20021123050047/http://www.dynport.com/|Website (earliest archive)]]
 +  * [[https://wiki.whiteroseintelligence.com/en/DynPort-Vaccine-Company|White Rose Wiki]]
Back to top